LYTTON LAURENCE W 13D and 13G filings for Evoke Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-13 1:32 pm Purchase |
2024-02-09 | 13G | Evoke Pharma, Inc. EVOK |
LYTTON LAURENCE W | 71,610 9.990% |
71,610 (New Position) |
Filing |